First Cited
Last Cited

Articles citing This Document (Page 1 of 2)

Anti‐monoclonal antibody treatment during pregnancy and lactation in women with multiple sclerosis or neuromyelitis optica spectrum disorder
Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 20212022
Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 20202022
Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different2022
Quality of life of children with mucopolysaccharidoses on the background of enzyme replacement therapy2022
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective studyJournal of Cancer Research and Clinical Oncology
The Price and Market Share Evolution of the Original Biologics and Their Biosimilars in FinlandBioDrugs2022
Seizure medication and planned pregnancy: balancing the risks and outcomesExpert Review of Neurotherapeutics
Metastatic renal cell cancer and first-line combinations: for which patients? (focus on tolerance and health-related quality of life)Bulletin Du Cancer2022
Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical ExperienceBioDrugs
Data-sharing and re-analysis for main studies assessed by the European Medicines Agency-a cross-sectional study on European Public Assessment Reports.BMC Medicine2022
Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials.JAMA Internal Medicine2022
The characteristics of patents impacting availability of biosimilars.Nature Biotechnology2022
Potential Adverse Events Reported With the Janus Kinase Inhibitors Approved for the Treatment of Rheumatoid Arthritis Using Spontaneous Reports and Online Patient Reviews.Frontiers in Pharmacology2021
Effectiveness of Vaccination against SARS-CoV-2 Infection in the Pre-Delta Era: A Systematic Review and Meta-Analysis.Vaccines2022
Hazardous drugs (NIOSH's list-group 1) in healthcare settings: Also a hazard for the environment?Science of the Total Environment2022
Renal Safety Profile of EGFR Targeted Therapies: A Study from VigiBase the WHO Global Database of Individual Case Safety ReportsCancers2021
Cooperation in Pharmaceutical DevelopmentStudies in Systems, Decision and Control2021
Impact of non-formulary drugs on pharmacological prescription in hospitalised patientsEuropean Journal of Hospital Pharmacy2021
AIFA time-to-reimbursement: a comparison between the last two committees from 2015 to 2020Global & Regional Health Technology Assessment2020
Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic OptionsDermatology and Therapy2021
Monoclonal Antibodies for Protozoan Infections: A Future Reality or a Utopic Idea?Frontiers in Medicine2021
Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III StudyBioDrugs2021
Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory PerspectiveDrugs2021
Checkpoint-Inhibition bei TumorerkrankungenOnkologe2021
Free-of-charge medicine schemes in the NHS: A local and regional drug and therapeutic committee's experienceBritish Journal of Clinical Pharmacology2021
Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and EuropeJAMA Oncology2021
A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on TildrakizumabFrontiers in Medicine2021
Cost to Medicare of Delayed Adalimumab Biosimilar AvailabilityClinical Pharmacology and Therapeutics2021
Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesisPharmacology Research and Perspectives2021
Glutamate and depression: Reflecting a deepening knowledge of the gut and brain effects of a ubiquitous moleculeWorld Journal of Psychiatry2021
Equivalence and switching between biosimilars and reference molecules in rheumatoid arthritis: protocol for a systematic review and meta-analysisSystematic Reviews2021
Oncology Products in the European Union: An Analysis of Regulatory Approvals with a CHMP Oral ExplanationTherapeutic Innovation and Regulatory Science2021
Recent developments of HDAC inhibitors: Emerging indications and novel moleculesBritish Journal of Clinical Pharmacology2021
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated ApprovalJAMA Internal Medicine2021
Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug ProductsPharmaceutical Research2021
Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in DogsFrontiers in Veterinary Science2021
Dynamics of patents, orphan drug designation, licensing, and revenues from drugs for rare diseases: The market expansion of eculizumabPLoS ONE2021
The Role of the Pathologist in the Next-Generation Era of Tumor Molecular CharacterizationDiagnostics2021
A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight LossFrontiers in Pharmacology2020
Molecular engineering of antimicrobial peptides: microbial targets, peptide motifs and translation opportunitiesBiophysical Reviews2021
An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004-2018)Perspectives in Clinical Research2021
The Framingham cardiovascular risk score and 5-year progression of multiple sclerosisEuropean Journal of Neurology2021
Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysisExpert Review of Clinical Immunology2021
Aggressiveness of end-of-life cancer care: what happens in clinical practice?Supportive Care in Cancer2021
Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer SurgeryAnnals of Surgical Oncology2021
Use of SGLT2 Inhibitors in Older Adults: Scientific Evidence and Practical AspectsDrugs and Aging2020
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A ReviewClinical Pharmacokinetics2020
FDA and EMA Approvals of New Breast Cancer Drugs-A Comparative Regulatory AnalysisCancers2020
Clinical development success rates and social value of pediatric Phase 1 trials in oncologyPLoS ONE2020